Aster DM Healthcare reported a remarkable 77% increase in net profit for the fourth quarter of the financial year 2025-26 (FY26), reaching ₹140 crore ($17 million USD). Revenue from operations also saw an 18% rise, totaling ₹1,182 crore ($142 million USD). The strong profit growth was attributed to robust performances across core hospitals, clinics, and the laboratory business. Notably, average revenue per inpatient increased by 9% to ₹1,25,234 ($1,500 USD), while total patient volumes grew by 15%, driven by both inpatient and outpatient services. The medical value travel segment experienced a 41% increase, particularly in Kerala, which recorded a 51% rise in this area. Furthermore, the company is advancing its merger with Blackstone and TPG, having completed a preferential allotment of approximately 3.6% stake following shareholder approval. The merger awaits final regulatory clearances and is expected to conclude in the first quarter of FY27. Overall, Aster DM Healthcare's performance reflects strong operational efficiency and growth across its various segments.